Utama › Kanser Endometrium › Texas › Fort Worth
Kajian klinikal Kanser Endometrium di Fort Worth, TX
12 kajian untuk Kanser Endometrium sedang mencari peserta di lokasi dalam dan sekitar Fort Worth (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- START Center for Clinical Research, Fort Worth
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Mengambil pesertaFasa 2
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Mengambil pesertaFasa 1/2
- START Dallas Fort Worth, Fort Worth
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Mengambil pesertaFasa 3
- Texas Oncology - DFW ( Site 8004), Fort Worth
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
- Start - Dfw, Fort Worth
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Mengambil pesertaFasa 3
- USOR - Texas Oncology - Dallas Fort Worth (DFW), Fort Worth
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Mengambil pesertaFasa 3
- Research Site, Fort Worth
A Study of PHST001 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- START Center for Cancer Research - Texas, Fort Worth
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Mengambil pesertaFasa 1/2
- USOR Texas Oncology, Fort Worth
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Mengambil pesertaFasa 1
- UT Southwestern - Simmons Cancer Center - Fort Worth, Fort Worth
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Mengambil pesertaFasa 1
- START Dallas Fort Worth, LLC, Fort Worth
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Mengambil pesertaFasa 2/3
- Texas Oncology-Fort Worth Cancer Center, Fort Worth
Kajian Kanser Endometrium di bandar lain
- Houston, TX68 kajian
- New York City, NY52 kajian
- Boston, MA50 kajian
- Arlington, VA39 kajian
- Nashville, TN38 kajian
- Los Angeles, CA34 kajian
- St. Louis, MO29 kajian
- Philadelphia, PA28 kajian
- San Antonio, TX27 kajian
- Chicago, IL25 kajian
- Columbus, OH25 kajian
- Queens, NY25 kajian
Kajian lain di Fort Worth
- Kanser Paru-paru Bukan Sel Kecil18 kajian
- Kanser Ovari17 kajian
- Kanser Payudara11 kajian
- Kanser (semua jenis)9 kajian
- Kanser Prostat9 kajian
- Kegagalan Jantung7 kajian
- Kanser Kolorektal7 kajian
- Kanser Payudara Triple-Negatif7 kajian
- Kanser Metastatik7 kajian
- Kanser Ginjal (Karsinoma Sel Renal)7 kajian
- Kolitis Ulseratif7 kajian
- Degenerasi Makula7 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.